PregInPoxVac | MATERNAL AND INFANT SAFETY AND IMMUNOGENICITY IN A PHASE 3, OPEN-LABEL, RANDOMISED, VACCINE TRIAL OF A TWO-DOSE MPOX VACCINE
01-08-2024
-31-07-2027
Show more information
Organisation
AFRICA CLINICAL RESEARCH MANAGEMENTLIMITED